Literature DB >> 17321669

PTHrP P3 promoter activity in breast cancer cell lines: role of Ets1 and CBP (CREB binding protein).

Hinda Hamzaoui1, Marthe Rizk-Rabin, Jonthan Gordon, Carlos Offutt, Jérôme Bertherat, Zhor Bouizar.   

Abstract

Parathyroid hormone-related protein (PTHrP) is produced by many tumors including breast cancer. We have reported that Ets1 factor activates P3 PTHrP promoter in our model of tumorigenic breast cancer cell and not in pre- or non-tumorigenic cell lines, thus contributing to an increased PTHrP production. In this study, gel retardation assays revealed that Etsl and its promoter binding site (EBS) specifically formed complexes whose abundance correlates with Ets1 levels in the three cell lines. Coexpression of Etsl and CBP induced a synergistic activation of the P3 promoter only in the tumorigenic cell line. This synergism required the integrity of the EBS and was abrogated by E1A. All breast cancer cell lines showed high basal concentrations of phosphorylated CREB. Moreover a CRE-like sequence was also required for Ets1/CBP synergy and, finally, CREB expression was found to enhance the PTHrP P3 promoter activity. Thus a multipartite complex of transcription factors and coactivators seems to regulate PTHrP transcription and contribute to the alterations that promote tumorigenic behavior in breast epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321669     DOI: 10.1016/j.mce.2007.01.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.

Authors:  Vandanajay Bhatia; Ramanjaneya V Mula; Miriam Falzon
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

2.  A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E.

Authors:  Philipp G Maass; Jutta Wirth; Atakan Aydin; Andreas Rump; Sigmar Stricker; Sigrid Tinschert; Miguel Otero; Kaneyuki Tsuchimochi; Mary B Goldring; Friedrich C Luft; Sylvia Bähring
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

3.  DNA plasticity is a key determinant of the energetics of binding of Jun-Fos heterodimeric transcription factor to genetic variants of TGACGTCA motif.

Authors:  Kenneth L Seldeen; Caleb B McDonald; Brian J Deegan; Vikas Bhat; Amjad Farooq
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

4.  Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation.

Authors:  Tomohiro Itoh; Yuko Ito; Yoshinori Ohtsuki; Masashi Ando; Yasuyuki Tsukamasa; Nami Yamada; Tomoki Naoe; Yukihiro Akao
Journal:  J Mol Histol       Date:  2012-04-17       Impact factor: 2.611

5.  lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.

Authors:  Fubo Chen; Shengcai Qi; Xu Zhang; Jinjin Wu; Xi Yang; Raorao Wang
Journal:  Int J Oncol       Date:  2019-02-01       Impact factor: 5.650

6.  Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.

Authors:  Yan Luo; Fengli He; Li Hu; Luo Hai; Meifeng Huang; Zhipeng Xu; Jingjing Zhang; Zhiguang Zhou; Feng Liu; Yan-Shan Dai
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.